Compliance & Medical Disclaimer
This article is for informational and educational purposes only and does not constitute medical, legal, regulatory, or professional advice. The compounds discussed are research chemicals not approved for human consumption by the US FDA, European Medicines Agency (EMA), UK MHRA, Australian TGA, Health Canada, or any other major regulatory authority. They are sold strictly for laboratory research use. WolveStack does not employ medical staff, does not diagnose, treat, or prescribe, and makes no health claims under FTC, UK ASA, EU MDR/UCPD, or AU TGA standards. Always consult a licensed healthcare professional in your jurisdiction before considering any peptide protocol. This site contains affiliate links (FTC 2023 endorsement guidelines compliant); we may earn a commission on qualifying purchases at no additional cost to you. Some compounds discussed are on the WADA prohibited list — competitive athletes should verify current status with their governing body before any research use. Use of research chemicals may be illegal in your jurisdiction.
Reviewed by: WolveStack Research Team
Last reviewed: 2026-04-28
Editorial policy
Editorial review process: WolveStack Research Team — collective expertise in peptide pharmacology, regulatory science, and research literature analysis. We synthesize peer-reviewed studies, regulatory filings, and clinical trial data; we do not provide medical advice or treatment recommendations. Content is reviewed and updated as new evidence emerges.
Medical Disclaimer
This article is for informational and educational purposes only and does not constitute medical advice. The compounds discussed are research chemicals that are not FDA-approved for human use. Always consult a licensed healthcare professional before considering any peptide protocol. WolveStack has no medical staff and does not diagnose, treat, or prescribe. See our full disclaimer.
Trusted Research-Grade Sources
Below are the two vendors we recommend for research peptides — both publish independent third-party Certificates of Analysis (COAs) and ship internationally. Affiliate links: we earn a small commission at no extra cost to you (see Affiliate Disclosure).
Frequently Asked Questions
Does MK-677 cause permanent side effects?
Most MK-677 side effects are temporary and reversible upon cessation. Water retention, increased appetite, and lethargy typically resolve within 2-4 weeks after stopping. Long-term metabolic changes like insulin resistance may take longer to normalize—sometimes 6-12 weeks. Prolactin typically returns to baseline within 2-4 weeks. No permanent organ damage has been documented in human studies, though long-term safety data beyond 12 months is limited. The key is avoiding long or excessive cycles that compound metabolic stress.
How long does water retention from MK-677 last?
Water retention from MK-677 typically appears within 1-2 weeks of starting and plateaus around 2-5 lbs in most users. Peak bloating usually occurs in weeks 2-3. Most of this water weight resolves within 2-3 weeks after discontinuation, though some users experience lingering puffiness for up to 4 weeks. Sodium restriction and aggressive hydration during the cycle can minimize severity. Post-cycle, simply returning to normal sodium intake accelerates fluid loss.
Can MK-677 cause diabetes?
MK-677 doesn't directly cause diabetes, but it does impair insulin sensitivity and elevate fasting glucose, particularly with long-term use or higher doses. This significantly increases risk in predisposed individuals (pre-diabetics, metabolic syndrome, family history of type 2 diabetes). For someone with healthy baseline glucose and insulin, short cycles rarely progress to clinical diabetes. However, if you already have elevated fasting glucose (110+ mg/dL) or HbA1c above 5.7%, MK-677 should be avoided. Regular blood glucose monitoring is essential during cycles.
Should I take MK-677 at night to reduce side effects?
Yes, taking MK-677 in the evening (2-3 hours before bed) is the standard protocol and directly reduces side effects. Evening dosing aligns with natural GH pulsatility during sleep, leveraging your body's existing circadian rhythm. More importantly, it puts the appetite surge during sleep rather than your workday, making it far easier to manage. Fatigue and lethargy also hit when you're sleeping. If you take MK-677 in the morning, you'll experience intense hunger and reduced energy throughout the day, making adherence and performance much harder.
What blood tests should I get before starting MK-677?
Pre-cycle baseline testing should include: fasting glucose, fasting insulin, HbA1c, lipid panel (total cholesterol, LDL, HDL, triglycerides), liver function tests (ALT/AST), kidney function (creatinine/BUN), prolactin, IGF-1, and complete blood count. Optional but recommended: thyroid panel. These establish baseline metabolic health and allow you to identify red flags. If fasting glucose is already elevated or you have metabolic syndrome markers, reconsider using MK-677. Repeat testing at mid-cycle (week 6-8) and post-cycle (2 weeks after cessation) shows what normalized and what persists.
Related Reading